Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Steven Yakubov Added: 5 years ago
Dr Steven Yakubov (OhioHealth Riverside Methodist Hospital, Columbus, OH, US) discusses 1-year outcomes of TAVR vs SAVR in patients at intermediate surgical risk - a propensity-match analysis from the SURTAVI trial. Filmed on site at CRT 2019 by Radcliffe Cardiology Questions: 1. Why did you conduct this analysis? 2. How was data collected and analysed? 3. What were your findings? 4. How… View more
Author(s): John Rawlins , Jehangir Din , Suneel Talwar , et al Added: 3 years ago
A bifurcation lesion within the coronary arterial circulation is defined as a stenosis occurring at, or adjacent to, a significant division of a major epicardial coronary artery.1 Bifurcation lesions account for 1–20% of all percutaneous coronary interventions (PCIs), and treatment remain technically challenging despite advances in PCI techniques and third-generation drug-eluting stent (DES)… View more
Author(s): Farouc Jaffer Added: 5 years ago
Dr. Farouc Jaffer discussesProcedural Outcomes of Multiple CTO Intervention Carried Out in the Same Procedure: Insight From a Multicenter CTO Registry Filmed by Radcliffe Cardiology on-site at ACC 2018 in Orlando, US. View more
Author(s): Federico M Asch Added: 5 years ago
Dr Federico M Asch (Washington Hospital Center, Washington DC, US) discusses echocardiographic outcomes from the COAPT trial - mitral regurgitation after MitraClip implantation in patients with HF and secondary mitral regurgitation.Filmed on-site at ACC 2019 by Radcliffe Cardiology. Videographer: Josh Birch Educational Lead: Liam O'Neill, Chief Operating Officer View more
Author(s): Apostolos Tzikas , Darren Mylotte , Martin Bergmann Added: 3 years ago
Atrial fibrillation (AF), the most common arrhythmia, is associated with a significantly increased risk of morbidity and mortality due to a fivefold increase in the frequency of thromboembolic stroke.1 The gold standard treatment for the prevention of AF-related thromboembolism is oral anticoagulation (OAC), based on an individualised patient risk assessment with either the CHADS2 or the CHA2DS2… View more
Author(s): Simon Kennon , John Webb Added: 8 years ago
The SAPIEN 3 Trials - One Year Outcomes Simon Kennon and John Webb at Euro PCR 2015 Dr Webb has kindly supplied access to this supporting slide set for viewers of this interview: View more
Author(s): Eline H Ploumen Added: 2 years ago
In this short video, Dr Eline H Ploumen (Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, NL) discusses the 5-yearoutcomesfrom the BIO-RESORT trial. The randomized trial compared the ultrathin-strut and very thin-strut biodegradable polymer DES to thin-strut durable polymer DES. At 1-year follow-up, non-inferiority of the two novel DES was showed. Discussion Points: Rationale… View more
Author(s): Harriette Van Spall , Steven E Nissen Added: 1 year ago
ACC.23/WCC — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by principal investigator, Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) to have a deep dive into the practice-changing CLEAR-Outcomes trial (NCT02993406).The Phase 3 CLEAR-Outcomes trial was conducted to evaluate the impact of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular… View more
Author(s): Aaisha Opel Added: 5 years ago
Dr Aaisha Opel discusses 'Empowering Teams to Improve Atrial Fibrillaiton Ablation Efficiency and Outcomes' at EHRA 2018. View more